Aptamer Group (UK) Today
| APTA Stock | 0.43 0.01 2.27% |
PerformanceGood
| Odds Of DistressQuite High
|
Aptamer Group is selling for under 0.43 as of the 25th of February 2025; that is 2.27 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.41. Aptamer Group has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 25th of February 2025. Click here to learn more.
Moving against Aptamer Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aptamer Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aptamer Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aptamer Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive Chairman | Stephen Hull |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Aptamer Group PLC (APTA) is traded on London Exchange in UK and employs 34 people. Aptamer Group is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aptamer Group's market, we take the total number of its shares issued and multiply it by Aptamer Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aptamer Group PLC operates under Biotechnology sector and is part of Health Care industry. The entity has 1.99 B outstanding shares.
Aptamer Group generates negative cash flow from operations
Check Aptamer Group Probability Of Bankruptcy
Ownership AllocationAptamer Group holds a total of 1.99 Billion outstanding shares. Aptamer Group PLC retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aptamer Ownership Details
Aptamer Group PLC Risk Profiles
Although Aptamer Group's alpha and beta are two of the key measurements used to evaluate Aptamer Group's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.31 | |||
| Semi Deviation | 2.84 | |||
| Standard Deviation | 4.88 | |||
| Variance | 23.79 |
Aptamer Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aptamer Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Aptamer Group Corporate Executives
Elected by the shareholders, the Aptamer Group's board of directors comprises two types of representatives: Aptamer Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptamer. The board's role is to monitor Aptamer Group's management team and ensure that shareholders' interests are well served. Aptamer Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptamer Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Rapson | CFO Secretary | Profile |
Additional Tools for Aptamer Stock Analysis
When running Aptamer Group's price analysis, check to measure Aptamer Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptamer Group is operating at the current time. Most of Aptamer Group's value examination focuses on studying past and present price action to predict the probability of Aptamer Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptamer Group's price. Additionally, you may evaluate how the addition of Aptamer Group to your portfolios can decrease your overall portfolio volatility.